|
1
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM: Recent advances in
neuroblastoma. N Engl J Med. 362:2202–2211. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Steeg PS: Tumor metastasis: mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nevo I, Oberthuer A, Botzer E, et al:
Gene-expression-based analysis of local and metastatic
neuroblastoma variants reveals a set of genes associated with tumor
progression in neuroblastoma patients. Int J Cancer. 126:1570–1581.
2010.
|
|
5
|
Gumbiner BM: Regulation of
cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol.
6:622–634. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ceteci F, Ceteci S, Karreman C, et al:
Disruption of tumor cell adhesion promotes angiogenic switch and
progression to micrometastasis in RAF-driven murine lung cancer.
Cancer Cell. 12:145–159. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Derksen PW, Liu X, Saridin F, et al:
Somatic inactivation of E-cadherin and p53 in mice leads to
metastatic lobular mammary carcinoma through induction of anoikis
resistance and angiogenesis. Cancer Cell. 10:437–449. 2006.
View Article : Google Scholar
|
|
8
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar
|
|
9
|
Vleminckx K, Vakaet L Jr, Mareel M, Fiers
W and van Roy F: Genetic manipulation of E-cadherin expression by
epithelial tumor cells reveals an invasion suppressor role. Cell.
66:107–119. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frixen UH, Behrens J, Sachs M, et al:
E-cadherin-mediated cell-cell adhesion prevents invasiveness of
human carcinoma cells. J Cell Biol. 113:173–185. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perl AK, Wilgenbus P, Dahl U, Semb H and
Christofori G: A causal role for E-cadherin in the transition from
adenoma to carcinoma. Nature. 392:190–193. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O’Donnell KA, Wentzel EA, Zeller KI, Dang
CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1
expression. Nature. 435:839–843. 2005.PubMed/NCBI
|
|
15
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: how many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo J, Dong Q, Fang Z, et al:
Identification of miRNAs that are associated with tumor metastasis
in neuroblastoma. Cancer Biol Ther. 9:446–452. 2010. View Article : Google Scholar
|
|
17
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoebeeck J, Michels E, Pattyn F, et al:
Aberrant methylation of candidate tumor suppressor genes in
neuroblastoma. Cancer Lett. 273:336–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paredes J, Figueiredo J, Albergaria A, et
al: Epithelial E- and P-cadherins: role and clinical significance
in cancer. Biochim Biophys Acta. 1826:297–311. 2012.PubMed/NCBI
|
|
21
|
Jiang T, Jiang H, Su XM, et al:
Expressions of E-cadherin and alpha-catenin in benign, malignant
and metastatic prostate tumors. Zhonghua Nan Ke Xue. 18:499–503.
2012.(In Chinese).
|
|
22
|
Larue L, Ohsugi M, Hirchenhain J and
Kemler R: E-cadherin null mutant embryos fail to form a
trophectoderm epithelium. Proc Natl Acad Sci USA. 91:8263–8267.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karayiannakis AJ, Syrigos KN, Savva A,
Polychronidis A, Karatzas G and Simopoulos C: Serum E-cadherin
concentrations and their response during laparoscopic and open
cholecystectomy. Surg Endosc. 16:1551–1554. 2002. View Article : Google Scholar
|
|
24
|
Alexiou D, Karayiannakis AJ, Syrigos KN,
et al: Serum levels of E-selectin, ICAM-1 and VCAM-1 in colorectal
cancer patients: correlations with clinicopathological features,
patient survival and tumour surgery. Eur J Cancer. 37:2392–2397.
2001. View Article : Google Scholar
|
|
25
|
Cavallaro U and Christofori G: Cell
adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev
Cancer. 4:118–132. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karatzas G, Karayiannakis AJ, Syrigos KN,
et al: E-cadherin expression correlates with tumor differentiation
in colorectal cancer. Hepatogastroenterology. 46:232–235.
1999.PubMed/NCBI
|
|
27
|
Karayiannakis AJ, Syrigos KN, Chatzigianni
E, et al: Aberrant E-cadherin expression associated with loss of
differentiation and advanced stage in human pancreatic cancer.
Anticancer Res. 18:4177–4180. 1998.PubMed/NCBI
|
|
28
|
Karayiannakis AJ, Syrigos KN, Chatzigianni
E, Papanikolaou S and Karatzas G: E-cadherin expression as a
differentiation marker in gastric cancer. Hepatogastroenterology.
45:2437–2442. 1998.PubMed/NCBI
|
|
29
|
Syrigos KN, Krausz T, Waxman J, et al:
E-cadherin expression in bladder cancer using formalin-fixed,
paraffin-embedded tissues: correlation with histopathological
grade, tumour stage and survival. Int J Cancer. 64:367–370. 1995.
View Article : Google Scholar
|
|
30
|
Berx G, Becker KF, Höfler H and van Roy F:
Mutations of the human E-cadherin (CDH1) gene. Hum Mutat.
12:226–237. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maretzky T, Reiss K, Ludwig A, et al:
ADAM10 mediates E-cadherin shedding and regulates epithelial
cell-cell adhesion, migration, and beta-catenin translocation. Proc
Natl Acad Sci USA. 102:9182–9187. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strathdee G: Epigenetic versus genetic
alterations in the inactivation of E-cadherin. Semin Cancer Biol.
12:373–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Voorhoeve PM, le Sage C, Schrier M, et al:
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in
testicular germ cell tumors. Cell. 124:1169–1181. 2006. View Article : Google Scholar
|
|
34
|
Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21
targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol
Chem. 282:14328–14336. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Y, Zhao J, Zhang PY, et al:
MicroRNA-10b targets E-cadherin and modulates breast cancer
metastasis. Med Sci Monit. 18:BR299–308. 2012.PubMed/NCBI
|
|
37
|
Xu X, Chen Z, Zhao X, et al: MicroRNA-25
promotes cell migration and invasion in esophageal squamous cell
carcinoma. Biochem Biophys Res Commun. 421:640–645. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cao M, Seike M, Soeno C, et al: MiR-23a
regulates TGF-β-induced epithelial-mesenchymal transition by
targeting E-cadherin in lung cancer cells. Int J Oncol. 41:869–875.
2012.
|
|
39
|
Zhu LH, Liu T, Tang H, et al: MicroRNA-23a
promotes the growth of gastric adenocarcinoma cell line MGC803 and
downregulates interleukin-6 receptor. FEBS J. 277:3726–3734. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang S, He X, Ding J, et al: Upregulation
of miR-23a approximately 27a approximately 24 decreases
transforming growth factor-beta-induced tumor-suppressive
activities in human hepatocellular carcinoma cells. Int J Cancer.
123:972–978. 2008. View Article : Google Scholar
|
|
41
|
Jahid S, Sun J, Edwards RA, et al: miR-23a
promotes the transition from indolent to invasive colorectal
cancer. Cancer Discov. 2:540–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Z, Wei W and Sarkar FH: miR-23a, a
critical regulator of ‘migR’ation and metastasis in colorectal
cancer. Cancer Discov. 2:489–491. 2012.
|
